Our study demonstrated that over-expression of versican G3 in mammary cell lines with low basal versican expression (ie. 66c14 cells) enhanced mammary cancer growth through up-regulating active EGFR expression and activating the EGFR/ERK pathway. This evidence concerns the gene EGFR and breast cancer.